blend labs inc - BLND

BLND

Close Chg Chg %
1.53 -0.11 -7.21%

Closed Market

1.42

-0.11 (7.21%)

Volume: 4.26M

Last Updated:

Apr 10, 2026, 3:59 PM EDT

Company Overview: blend labs inc - BLND

BLND Key Data

Open

$1.51

Day Range

1.41 - 1.53

52 Week Range

1.41 - 4.49

Market Cap

$393.38M

Shares Outstanding

257.11M

Public Float

178.74M

Beta

1.22

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.10

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

5.29M

 

BLND Performance

1 Week
 
-23.50%
 
1 Month
 
-1.92%
 
3 Months
 
-53.50%
 
1 Year
 
-50.16%
 
5 Years
 
N/A
 

BLND Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 6
Full Ratings ➔

About blend labs inc - BLND

Blend Labs, Inc. is a digital origination platform serving banks, credit unions, and mortgage lenders. It operates through the Blend Platform and Title segments. The Blend Platform segment consists of a suite of products that power the entire origination process from back-end workflows to consumer experience. The Title segment includes a suite of title products and services, such as instant title and other title search options, insurance solutions, closing and settlement services, including mobile signing and e-sign capabilities, and various post-closing solutions, such as disbursement and recording handling. The company was founded by Nima Ghamsari, Rosco Hill, Eugene Marinelli, and Erin James Collard on April 17, 2012 and is headquartered in Novato, CA.

BLND At a Glance

Blend Labs, Inc.
7250 Redwood Boulevard
Novato, California 94945
Phone 1-650-550-4810 Revenue 123.59M
Industry Packaged Software Net Income -25,887,000.00
Sector Technology Services Employees 419
Fiscal Year-end 12 / 2026
View SEC Filings

BLND Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 6.37
Price to Book Ratio N/A
Price to Cash Flow Ratio 68.38
Enterprise Value to EBITDA -57.063
Enterprise Value to Sales 7.119
Total Debt to Enterprise Value 0.183

BLND Efficiency

Revenue/Employee 294,952.267
Income Per Employee -61,782.816
Receivables Turnover 8.795
Total Asset Turnover 0.71

BLND Liquidity

Current Ratio 2.435
Quick Ratio 2.435
Cash Ratio 1.732

BLND Profitability

Gross Margin 72.453
Operating Margin -16.882
Pretax Margin -0.71
Net Margin -20.947
Return on Assets -11.51
Return on Equity N/A
Return on Total Capital -15.35
Return on Invested Capital -18.517

BLND Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 123.351
Total Debt to Total Assets 94.664
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 123.156
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Blend Labs Inc - BLND

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
235.20M 156.85M 162.02M 123.58M
Sales Growth
+0.30% -33.31% +3.30% -23.72%
Cost of Goods Sold (COGS) incl D&A
153.96M 75.71M 72.54M 34.04M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
14.42M 5.76M 5.89M 5.45M
Depreciation
5.95M 5.70M 4.33M 3.82M
Amortization of Intangibles
- 8.47M 64.00K 489.00K
COGS Growth
+21.57% -50.82% -4.18% -53.07%
Gross Income
81.24M 81.14M 89.48M 89.54M
Gross Income Growth
-24.68% -0.13% +10.28% +0.07%
Gross Profit Margin
+34.54% +51.73% +55.23% +72.45%
2022 2023 2024 2025 5-year trend
SG&A Expense
362.46M 212.41M 131.63M 110.41M
Research & Development
138.09M 81.59M 46.09M 32.84M
Other SG&A
224.37M 130.82M 85.54M 77.56M
SGA Growth
+22.21% -41.40% -38.03% -16.12%
Other Operating Expense
- - - -
-
Unusual Expense
464.95M 24.95M 3.73M 871.00K
EBIT after Unusual Expense
(746.18M) (156.22M) (45.88M) (21.73M)
Non Operating Income/Expense
4.92M 7.25M 9.32M 20.86M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- 24.79M 30.81M 6.75M
Interest Expense Growth
+119.79% +24.29% -78.10% -100.00%
Gross Interest Expense
- 24.79M 30.81M 6.75M
Interest Capitalized
- - - -
-
Pretax Income
(766.05M) (179.78M) (43.31M) (878.00K)
Pretax Income Growth
-268.24% +76.53% +75.91% +97.97%
Pretax Margin
-325.70% -114.63% -26.73% -0.71%
Income Tax
(2.24M) 94.00K 109.00K 249.00K
Income Tax - Current - Domestic
355.00K 41.00K 64.00K 79.00K
Income Tax - Current - Foreign
268.00K 87.00K 11.00K 170.00K
Income Tax - Deferred - Domestic
- - - (2.86M)
-
Income Tax - Deferred - Foreign
- - (34.00K) 34.00K
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
(48.44M) (6.63M) (17.14M) (19.09M)
Consolidated Net Income
(812.25M) (186.51M) (60.56M) (20.21M)
Minority Interest Expense
(43.64M) (1.19M) (74.00K) (182.00K)
Net Income
(768.61M) (185.32M) (60.48M) (20.03M)
Net Income Growth
-348.58% +75.89% +67.36% +66.88%
Net Margin Growth
-326.79% -118.15% -37.33% -16.21%
Extraordinaries & Discontinued Operations
- - - (5.86M)
-
Discontinued Operations
- - - (5.86M)
-
Net Income After Extraordinaries
(768.61M) (185.32M) (60.48M) (25.89M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(768.61M) (185.32M) (60.48M) (25.89M)
EPS (Basic)
-3.2824 -0.7558 -0.2382 -0.1
EPS (Basic) Growth
-341.24% +76.97% +68.48% +58.02%
Basic Shares Outstanding
234.16M 245.21M 253.92M 258.95M
EPS (Diluted)
-3.2824 -0.7558 -0.2382 -0.1
EPS (Diluted) Growth
-341.24% +76.97% +68.48% +58.02%
Diluted Shares Outstanding
234.16M 245.21M 253.92M 258.95M
EBITDA
(266.81M) (125.51M) (36.26M) (15.42M)
EBITDA Growth
-52.52% +52.96% +71.11% +57.48%
EBITDA Margin
-113.44% -80.02% -22.38% -12.48%

Snapshot

Average Recommendation BUY Average Target Price 3.75
Number of Ratings 6 Current Quarters Estimate 0.022
FY Report Date 06 / 2026 Current Year's Estimate 0.074
Last Quarter’s Earnings 0.01 Median PE on CY Estimate N/A
Year Ago Earnings 0.01 Next Fiscal Year Estimate 0.122
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 5 5 5 5
Mean Estimate 0.02 0.02 0.07 0.12
High Estimates 0.03 0.03 0.10 0.16
Low Estimate 0.01 0.02 0.04 0.07
Coefficient of Variance 38.03 22.82 29.61 28.04

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 5
OVERWEIGHT 0 0 0
HOLD 1 1 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Overweight

Insider Actions for Blend Labs Inc - BLND

Date Name Shares Transaction Value
Jan 12, 2026 Oxana Tkach PRINCIPAL ACCOUNTING OFFICER 77,017 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $3.09 per share 237,982.53
Sep 10, 2025 Eric H. Woersching Director 30,000 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $4 per share 120,000.00
Aug 13, 2025 Winnie Ling HEAD OF LEGAL AND PEOPLE 372,018 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $3.62 per share 1,346,705.16
Jul 18, 2025 Brian Kneafsey Head of Revenue 721,598 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $3.63 per share 2,619,400.74
Jul 18, 2025 Brian Kneafsey Head of Revenue 746,598 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $3.42 per share 2,553,365.16
Jul 18, 2025 Eric H. Woersching Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 18, 2025 Eric H. Woersching Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2025 Erin N. Lantz Director 87,760 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2025 Erin N. Lantz Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2025 Erin N. Lantz Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2025 Timothy J. Mayopoulos Director 381,130 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2025 Gerald C. Chen Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2025 Gerald C. Chen Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2025 Gerald C. Chen Director 87,760 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2025 Bryan E. Sullivan Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2025 Bryan E. Sullivan Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2025 Bryan E. Sullivan Director 50,000 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 17, 2025 Timothy J. Mayopoulos Director 50,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 17, 2025 Timothy J. Mayopoulos Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Blend Labs Inc in the News